StreetInsider.com News Articles

AsymBio Secures US$184 Million Capital Injection to Support Long-Term Growth

Tue, 04 Aug 2026 08:30:00 -0400

SHANGHAI, Aug. 4, 2026 /PRNewswire/ -- AsymBio, a biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of Asymchem Group (stock codes: 002821.SZ / 6821.HK), today announced a total capital injection of RMB 1.2397 billion (approximately US$184 million) into AsymBio by Asymchem Group, Hillhouse Qirui and other investors.

AsymBio Secures US$184 Million Capital Injection to Support Long-Term Growth

Tue, 04 Aug 2026 08:30:00 -0400

AsymBio Secures US$184 Million Capital Injection to Support Long-Term Growth

Tue, 04 Aug 2026 08:30:00 -0400

AsymBio Secures US$184 Million Capital Injection to Support Long-Term Growth

Tue, 04 Aug 2026 08:30:00 -0400

AsymBio Secures US$184 Million Capital Injection to Support Long-Term Growth

Tue, 04 Aug 2026 08:30:00 -0400

AsymBio Secures US$184 Million Capital Injection to Support Long-Term Growth

Tue, 04 Aug 2026 08:30:00 -0400

AsymBio Secures US$184 Million Capital Injection to Support Long-Term Growth

Tue, 04 Aug 2026 08:30:00 -0400

AsymBio Secures US$184 Million Capital Injection to Support Long-Term Growth

Tue, 04 Aug 2026 08:30:00 -0400

AsymBio Kicks Off Construction of Fengxian R&D Building to Establish a Full-Lifecycle, One-Stop Biologics Service Ecosystem

Mon, 27 Jul 2026 09:00:00 -0400

SHANGHAI, July 27, 2026 /PRNewswire/ -- AsymBio, a biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of Asymchem Group (stock codes: 002821.SZ / 6821.HK), today announced that construction of its new R&D building has officially broken ground at the Shanghai Fengxian site. The project marks a pivotal infrastructure step in strengthening AsymBio's biologics CDMO capabilities and reinforcing the Fengxian site's role as a core development-and-manufacturing hub.

AsymBio Kicks Off Construction of Fengxian R&D Building to Establish a Full-Lifecycle, One-Stop Biologics Service Ecosystem

Mon, 27 Jul 2026 09:00:00 -0400

AsymBio Kicks Off Construction of Fengxian R&D Building to Establish a Full-Lifecycle, One-Stop Biologics Service Ecosystem

Mon, 27 Jul 2026 09:00:00 -0400

AsymBio Kicks Off Construction of Fengxian R&D Building to Establish a Full-Lifecycle, One-Stop Biologics Service Ecosystem

Mon, 27 Jul 2026 09:00:00 -0400

AsymBio Kicks Off Construction of Fengxian R&D Building to Establish a Full-Lifecycle, One-Stop Biologics Service Ecosystem

Mon, 27 Jul 2026 09:00:00 -0400

AsymBio Kicks Off Construction of Fengxian R&D Building to Establish a Full-Lifecycle, One-Stop Biologics Service Ecosystem

Mon, 27 Jul 2026 09:00:00 -0400

AsymBio Kicks Off Construction of Fengxian R&D Building to Establish a Full-Lifecycle, One-Stop Biologics Service Ecosystem

Mon, 27 Jul 2026 09:00:00 -0400

AsymBio Kicks Off Construction of Fengxian R&D Building to Establish a Full-Lifecycle, One-Stop Biologics Service Ecosystem

Mon, 27 Jul 2026 09:00:00 -0400

AsymBio Establishes Integrated Technology Platforms Spanning the Full Biopharmaceutical Development Lifecycle